AVANIR Pharmaceuticals (AVNR) to Present at RBC Capital Markets' 2013 Global Healthcare Conference  
2/15/2013 6:45:30 AM

ALISO VIEJO, Calif., Feb. 14, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the RBC Capital Markets' 2013 Global Healthcare Conference.

  • Location: Palace Hotel, New York, NY
  • Presentation date: Tuesday February 26, 2013
  • Presentation time: 4:35 p.m. ET

A live webcast and 30-day archive of this presentation will be available at

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit

AVANIRĀ® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.

Ā©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.


Avanir Investor & Media Contact
Ian Clements, PhD
+1 (949) 389-6700

SOURCE Avanir Pharmaceuticals, Inc.